subject: MESH:C586502

subject_name: tegafur-gimeracil-oteracil

object_name: nasopharyngeal carcinoma


subject: MESH:C586502

object_name: nasopharyngeal carcinoma, susceptibility to, 1

tested_intervention: yes


subject: CHEBI:4911

subject_name: Etoposide

object_name: neoplastic meningitis

tested_intervention: unsure


subject: CHEBI:4911

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4445

subject_name: Desflurane

object_name: Aspiration


subject: CHEBI:9130

subject_name: Sevoflurane


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: Stress


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: PUBCHEM.COMPOUND:155977629


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: seborrheic dermatitis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:YUN2306954

subject_name: Cilofexor

object_name: primary biliary cholangitis


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: habitual spontaneous abortion


subject: UMLS:C4085978

subject_name: Anti-pd-1 checkpoint inhibitor pf-06801591

object_name: superficial urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:149504

object_name: myocardial ischemia


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:36796

subject_name: duloxetine

object_name: prostate carcinoma


subject: CHEBI:36796

object_name: prostate cancer


subject: CHEBI:3070

subject_name: Bestatin

object_name: lymphedema


subject: CHEBI:3070

object_name: Lymphedema, CTCAE


subject: UNII:I0J33N5627

subject_name: Ubenimex


subject: UNII:I0J33N5627


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: Egg allergy


subject: UNII:IFJ6X26JW6

subject_name: Apatorsen

object_name: squamous cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3039556

subject_name: APATORSEN


subject: UMLS:C2348994


subject: UNII:T1DQI1B52Y

subject_name: Miransertib

object_name: endometrial cancer


subject: UNII:T1DQI1B52Y

object_name: uterine corpus cancer


subject: UNII:T1DQI1B52Y

object_name: endometrial carcinoma


subject: UNII:T1DQI1B52Y

object_name: ovarian cancer


subject: UNII:T1DQI1B52Y

object_name: ovarian neoplasm


subject: UNII:T1DQI1B52Y

object_name: ovarian carcinoma


subject: UMLS:C3274586

subject_name: ARQ 092


subject: UMLS:C3274586


subject: UMLS:C3274586


subject: UMLS:C3274586


subject: UMLS:C3274586


subject: UMLS:C3274586


subject: CHEBI:2704

subject_name: Anastrozole


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704


subject: UMLS:C2698851

subject_name: POMx

object_name: arteriosclerosis disorder


subject: UMLS:C2698851

object_name: atherosclerosis


subject: CHEBI:32599

object_name: Agitation, CTCAE 3.0


subject: CHEBI:32599

object_name: Agitation


subject: CHEBI:32599

object_name: Agitation, CTCAE 5.0


subject: CHEBI:32599

object_name: Pediatric Disorder


subject: UNII:J81E81G364

subject_name: Efaproxiral

object_name: Disseminated Malignant Neoplasm


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: anaphylaxis


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Intubation complication


subject: UMLS:C4547221

object_name: scleroderma


subject: UMLS:C4547221

object_name: systemic sclerosis


subject: UMLS:C0597418

subject_name: Rotavirus Vaccines

object_name: pertussis


subject: UMLS:C0597418

object_name: diphtheria


subject: UMLS:C0597418

object_name: tetanus


subject: UMLS:C5397359

subject_name: Vaccine product containing only Rotavirus antigen (medicinal product)


subject: UMLS:C5397359


subject: UMLS:C5397359


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:134506

object_name: obesity


subject: PUBCHEM.COMPOUND:134506

object_name: Obesity, CTCAE


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: CHEBI:89608


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: Chronic small plaque psoriasis


subject: CHEBI:6970

subject_name: Mometasone


subject: CHEBI:30762

subject_name: salicylate


subject: CHEBI:9008

subject_name: salicylurate


subject: CHEBI:16914

subject_name: Salicylic acid


subject: CHEBI:9168

subject_name: Sirolimus

object_name: influenza


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: myelodysplastic syndrome with excess blasts-2


subject: CHEBI:4026

object_name: myelodysplastic syndrome with excess blasts-1


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Acute myeloid leukemia in remission


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: CD4+/CD56+ hematodermic neoplasm


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570

object_name: Refractory acute myeloid leukemia


subject: CHEBI:9570

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:85990

subject_name: Panobinostat

object_name: adult T-cell leukemia/lymphoma


subject: UNII:D07V79Q44T


subject: UMLS:C1566164


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Childhood Solid Neoplasm


subject: CHEBI:17549

object_name: Adult Solid Neoplasm


subject: CHEBI:17549

object_name: Solid Neoplasm


subject: UMLS:C4287766

object_name: gastroesophageal cancer


subject: CHEBI:167309

subject_name: Methadone

object_name: Opioid use, unspecified


subject: UMLS:C1134588

object_name: Myelodysplasia


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: vitiligo


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: gallbladder carcinoma


subject: UMLS:C4305781

object_name: migraine


subject: UMLS:C4305781

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Angina pectoris


subject: PUBCHEM.COMPOUND:24205

subject_name: VITAMIN E QUINONE

object_name: neuromuscular disease


subject: UNII:ZO763K43XR

subject_name: TOCOQUINONE


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: glioblastoma


subject: UNII:LKC0U3A8NJ

object_name: Childhood Glioblastoma


subject: UNII:LKC0U3A8NJ

object_name: adult glioblastoma


subject: UNII:LKC0U3A8NJ

object_name: malignant glioma


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:B2K5L1L8S9

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UNII:B2K5L1L8S9

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:B2K5L1L8S9

object_name: Adult Soft Tissue Sarcoma


subject: UNII:B2K5L1L8S9

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:B2K5L1L8S9

object_name: soft tissue sarcoma


subject: UNII:B2K5L1L8S9

object_name: colorectal cancer


subject: UNII:B2K5L1L8S9

object_name: colorectal carcinoma


subject: UNII:B2K5L1L8S9

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:93835

subject_name: Tolperisone

object_name: Muscle Cramp, CTCAE


subject: UMLS:C4762491

subject_name: Del Nido Cardioplegia

object_name: heart; surgery, heart, functional disturbance as result


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: HEAD INJURY TRAUMA BLUNT


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: UMLS:C0086135

subject_name: DDAVP


subject: CHEMBL.COMPOUND:CHEMBL2108632

subject_name: PLATELETS


subject: UMLS:C0443116

subject_name: Platelets Product


subject: CHEBI:134856

subject_name: Creatinolfosfate

object_name: Mature B-Cell Non-Hodgkin Lymphoma


subject: PR:000005036

subject_name: caspase recruitment domain-containing protein 16


subject: PR:000005619

subject_name: chymase


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Diabetic foot ulcer


subject: PUBCHEM.COMPOUND:2735

object_name: Wound Complication


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:134722

subject_name: Favipiravir

object_name: Coronavinae infectious disease


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: adverse effect


subject: PUBCHEM.COMPOUND:521372

object_name: Adverse effects


subject: PUBCHEM.COMPOUND:521372

object_name: Adverse reactions


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: UMLS:C0245925

subject_name: Prohance

object_name: multiple sclerosis


subject: CHEMBL.COMPOUND:CHEMBL3989780

subject_name: SUCRALFATE

object_name: eosinophilic esophagitis


subject: CHEMBL.COMPOUND:CHEMBL3989780

object_name: Eosinophilic infiltration of the esophagus


subject: GTOPDB:7055

subject_name: sucralfate


subject: GTOPDB:7055


subject: UNII:0BSC3P4H5X

subject_name: Vistusertib

object_name: Richter syndrome


subject: UNII:0BSC3P4H5X

object_name: diffuse large B-cell lymphoma


subject: UMLS:C0101999

object_name: influenza


subject: CHEBI:1879

subject_name: Tyrosol

object_name: cardiovascular disorder


subject: CHEBI:16865

subject_name: Aminobutyrates

object_name: Prediabetes


subject: CHEBI:16865

object_name: hypertension


subject: CHEBI:16865

object_name: Hypertension, CTCAE


subject: UMLS:C0016904

subject_name: gamma-aminobutyric acid


subject: UMLS:C0016904


subject: UMLS:C0016904


subject: CHEBI:8378

subject_name: Prednisolone

object_name: bronchiolitis


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:50634

object_name: metastatic melanoma


subject: CHEBI:50634

object_name: melanoma


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Tumor Mass


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:47426

object_name: neoplasm


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEMBL.COMPOUND:CHEMBL4298079

object_name: Kaposi Sarcoma


subject: CHEBI:50634

object_name: glaucoma


subject: CHEBI:50634

object_name: Glaucoma, CTCAE


subject: CHEBI:27690


subject: CHEBI:27690


subject: UNII:DA43GW06P1

subject_name: Methazolamide


subject: UNII:DA43GW06P1


subject: CHEBI:6822


subject: CHEBI:6822


subject: UMLS:C4724142

subject_name: Amorphous Calcium Carbonate

object_name: Osteopenia or osteoporosis


subject: UMLS:C4724142

object_name: rheumatoid arthritis


subject: CHEBI:18053

subject_name: 1-Aminocyclopropanecarboxylic Acid


subject: CHEBI:18053


subject: CHEBI:30526


subject: CHEBI:30526


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Postoperative delirium


subject: PUBCHEM.COMPOUND:57505028

object_name: Emergence Delirium


subject: PUBCHEM.COMPOUND:57505028

object_name: Sleep Fragmentation


subject: UMLS:C0376565

subject_name: Anti-HIV Agents

object_name: Liver Fibrosis


subject: UMLS:C0376565

object_name: liver cirrhosis


subject: UMLS:C0376565

object_name: hepatitis B


subject: UMLS:C0376565

object_name: alcoholic hepatitis


subject: UMLS:C0376565

object_name: liver carcinoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: central nervous system non-hodgkin lymphoma


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: chronic graft versus host disease


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:91899


subject: CHEBI:3207

subject_name: Budesonide


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: CHEBI:10023

subject_name: Voriconazole


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Adult idiopathic generalized osteoporosis


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C2224268

subject_name: meningococcal conjugate vaccine, serogroup A

object_name: meningitis


subject: UMLS:C2224268

object_name: Meningitis, CTCAE


subject: CHEBI:45021

subject_name: palmitoyl group

object_name: Helicobacter pylori infection


subject: CHEBI:51135

subject_name: poly(acrylamide) macromolecule


subject: CHEBI:60882

subject_name: poly(acrylamide) polymer


subject: CHEBI:15756

subject_name: Palmitic Acid


subject: UNII:5K543KNC5P

subject_name: Ibezapolstat

object_name: Clostridium difficile colitis


subject: UNII:5K543KNC5P

object_name: clostridium difficile infection


subject: UMLS:C5667100

subject_name: Anticachexia Agent OC514

object_name: Malignant cachexia


subject: MESH:D002214

subject_name: Capsules

object_name: Cirrhosis


subject: MESH:D002214


subject: MESH:D002214

object_name: alcohol-related liver disease


subject: MESH:D002214

object_name: alcohol abuse


subject: MESH:D002214

object_name: alcohol dependence


subject: CHEBI:9168

subject_name: Sirolimus

object_name: hyperinsulinism


subject: CHEBI:9168

object_name: Hyperinsulinemia


subject: UMLS:C5447515

subject_name: Carbon C 14 Fluzoparib

object_name: Childhood Solid Neoplasm


subject: UMLS:C5447515

object_name: Adult Solid Neoplasm


subject: UMLS:C5447515

object_name: Solid Neoplasm


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: otitis media


subject: CHEBI:4466

object_name: infectious otitis media


subject: CHEBI:4466

object_name: Otitis Media, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: cocaine dependence


subject: CHEBI:6538

subject_name: Loratadine

object_name: complications of organ transplant stem cells


subject: CHEBI:50730

subject_name: Montelukast

object_name: Signs and Symptoms, Respiratory


subject: CHEBI:50730

object_name: obstructive lung disease


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: glioblastoma


subject: PR:000017019

object_name: Childhood Glioblastoma


subject: PR:000017019

object_name: adult glioblastoma


subject: CHEBI:135813

subject_name: Flomoxef

object_name: urinary tract infection


subject: CHEBI:135813

object_name: bacterial urinary tract infection


subject: CHEBI:135813

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:95165

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:95165

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:95165

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:95165

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:95165

object_name: Mantle cell lymphoma stage III


subject: CHEBI:95165

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:95165

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:95165

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:95165

object_name: splenic marginal zone lymphoma


subject: CHEBI:95165

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:95165

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:95165

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:95165

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:95165

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:95165

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:95165

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:95165

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:95165

object_name: Marginal zone lymphoma stage III


subject: CHEBI:95165

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:95165

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:95165

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:95165

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:95165

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:95165

object_name: MALT lymphoma


subject: CHEBI:95165

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:95165

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:95165

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:95165

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:95165

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:95165

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:95165

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:95165

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:95165

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:95165

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:95165

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:95165

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:50131

subject_name: Decitabine

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:50131

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:50131

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:50131

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:50131

object_name: Mantle cell lymphoma stage III


subject: CHEBI:50131

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:50131

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:50131

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:50131

object_name: splenic marginal zone lymphoma


subject: CHEBI:50131

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:50131

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:50131

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:50131

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:50131

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:50131

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:50131

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:50131

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:50131

object_name: Marginal zone lymphoma stage III


subject: CHEBI:50131

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:50131

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:50131

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:50131

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:50131

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:50131

object_name: MALT lymphoma


subject: CHEBI:50131

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:50131

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:50131

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:50131

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:50131

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:50131

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:50131

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:50131

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:50131

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:50131

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:50131

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:50131

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: Gaucher disease


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: infertility


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:229649

subject_name: Leniolisib

object_name: immunodeficiency 14


subject: CHEBI:229649

object_name: activated PI3K-delta syndrome


subject: GTOPDB:9098

subject_name: carotuximab

object_name: primary peritoneal carcinoma


subject: GTOPDB:9098

object_name: papillary serous cystadenocarcinoma


subject: GTOPDB:9098

object_name: peritoneal carcinoma


subject: GTOPDB:9098

object_name: fallopian tube carcinoma


subject: GTOPDB:9098

object_name: Recurrent ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL2109321

subject_name: CAROTUXIMAB


subject: CHEMBL.COMPOUND:CHEMBL2109321


subject: CHEMBL.COMPOUND:CHEMBL2109321


subject: CHEMBL.COMPOUND:CHEMBL2109321


subject: CHEMBL.COMPOUND:CHEMBL2109321


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: avascular necrosis of femoral head, primary, 1


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C1950940

subject_name: Aclasta


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: glioblastoma


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: myofascial pain syndrome


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Myofascial Trigger Point Pain


subject: CHEBI:16796

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:16796

object_name: Dysmenorrhea


subject: CHEBI:16796

object_name: endometriosis


subject: UMLS:C1522385

subject_name: Recombinant Gonadotropin

object_name: Kallmann syndrome


subject: UMLS:C0018061

subject_name: Gonadotropins


subject: CHEBI:50114

subject_name: estrogen


subject: CHEMBL.COMPOUND:CHEMBL3989780

subject_name: SUCRALFATE

object_name: Radiation esophagitis


subject: GTOPDB:7055

subject_name: sucralfate


subject: CHEBI:9150

subject_name: Simvastatin

object_name: recurrent acute pancreatitis


subject: UMLS:C2348174

object_name: castration-resistant prostate carcinoma


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Stage III Prostate Cancer AJCC v8


subject: UNII:4Z63YK6E0E

object_name: Stage IIIB Prostate Cancer AJCC v8


subject: UNII:4Z63YK6E0E

object_name: Stage IIIA Prostate Cancer AJCC v8


subject: UNII:4Z63YK6E0E

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: UNII:4Z63YK6E0E

object_name: prostate adenocarcinoma


subject: UNII:4Z63YK6E0E

object_name: Testosterone Greater than 150 ng/dL


subject: UNII:3NU609VYNF


subject: UNII:3NU609VYNF


subject: UNII:3NU609VYNF


subject: UNII:3NU609VYNF


subject: UNII:3NU609VYNF


subject: UNII:3NU609VYNF


subject: CHEBI:9168

subject_name: Sirolimus

object_name: chronic liver failure


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: kidney failure


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: renal cell carcinoma


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: complications of organ transplant stem cells


subject: PUBCHEM.COMPOUND:6095520

object_name: Complication of labor and delivery, unspecified


subject: PUBCHEM.COMPOUND:6095520

object_name: postpartum hemorrhage


subject: PUBCHEM.COMPOUND:6095520

object_name: Post-partum hemorrhage


subject: PUBCHEM.COMPOUND:6095520

object_name: pregnancy related


subject: PUBCHEM.COMPOUND:89465

subject_name: Glucal


subject: PUBCHEM.COMPOUND:89465


subject: PUBCHEM.COMPOUND:89465


subject: PUBCHEM.COMPOUND:89465


subject: CHEBI:3309

subject_name: Calcium gluconate


subject: CHEBI:3309


subject: CHEBI:3309


subject: CHEBI:3309


subject: CHEBI:42797

subject_name: Gabapentin

object_name: glioblastoma


subject: CHEBI:42797

object_name: Childhood Glioblastoma


subject: CHEBI:42797

object_name: adult glioblastoma


subject: CHEBI:90683

subject_name: Talmapimod

object_name: Myelodysplasia


subject: CHEBI:90683

object_name: bone marrow neoplasm


subject: CHEBI:90683

object_name: hematologic disorder


subject: CHEBI:90683

object_name: bone marrow disorder


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: follicular lymphoma


subject: CHEBI:16016

subject_name: Glycerone

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Behcet's syndrome, vascular type


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:49603

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0006055

subject_name: Botulinum Toxins

object_name: Post-Operative Pain


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: hypoglycemia


subject: CHEBI:201431

object_name: Blood glucose below reference range (finding)


subject: CHEBI:201431

object_name: Hypoglycemia, CTCAE


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:70789204

object_name: type 1 diabetes mellitus


subject: CHEBI:134722

subject_name: Favipiravir

object_name: respiratory syncytial virus infectious disease


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: Colon Neoplasm


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: adolescent gender dysphoria


subject: UMLS:C5784955

subject_name: HMGB1 Inhibitor SB17170

object_name: Childhood Solid Neoplasm


subject: UMLS:C5784955

object_name: Adult Solid Neoplasm


subject: UMLS:C5784955

object_name: Solid Neoplasm


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: primary effusion lymphoma


subject: CHEBI:57694

object_name: Menopause related conditions


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:177438

subject_name: Nelotanserin

object_name: Visual hallucination


subject: CHEBI:177438

object_name: Lewy Bodies


subject: CHEBI:177438

object_name: REM sleep behavior disorder


subject: CHEBI:177438

object_name: Dementia associated with Parkinson's Disease


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: glioma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Nodule of lung


subject: CHEBI:4875

subject_name: Etanercept

object_name: adult dermatomyositis


subject: CHEBI:4875

object_name: dermatomyositis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: chronic pain (diagnosis)


subject: CHEBI:50731

object_name: Chronic pain


subject: UMLS:C5418140

subject_name: Protoves M1

object_name: bladder tumor


subject: UMLS:C5418140

object_name: urinary bladder carcinoma


subject: UMLS:C5418140

object_name: urinary bladder cancer


subject: UMLS:C5418140

object_name: childhood bladder carcinoma


subject: UMLS:C5418140

object_name: lower urinary tract symptom


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Rheumatic arthritis


subject: CHEBI:89324

object_name: rheumatic fever


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:ZR2110H6XE

subject_name: Sitravatinib Malate

object_name: uveal melanoma


subject: UMLS:C5419371


subject: UMLS:C3275210

subject_name: Galida

object_name: type 2 diabetes mellitus


subject: CHEBI:33252

subject_name: atomic nucleus

object_name: HIV infection


subject: CHEBI:33252

object_name: AIDS


subject: CHEBI:59897

subject_name: EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor


subject: CHEBI:59897


subject: UMLS:C0282519

subject_name: Reverse Transcriptase Inhibitors


subject: UMLS:C0282519


subject: CHEBI:75551


subject: UMLS:C1831888

object_name: metastatic colorectal cancer


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: end stage renal failure


subject: CHEBI:4696

object_name: Chronic uremia


subject: CHEBI:145499

subject_name: Donepezil


subject: CHEBI:145499


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: temporal arteritis


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen

object_name: Advanced Biliary Tract Carcinoma


subject: MESH:C508870

object_name: Advanced Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:135415564

subject_name: Rifabutin

object_name: Nontuberculous mycobacterial infection


subject: CHEBI:45367


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: poikiloderma with neutropenia


subject: CHEBI:71200

object_name: prurigo nodularis


subject: CHEMBL.COMPOUND:CHEMBL2109330

object_name: acute respiratory distress syndrome


subject: CHEBI:6931

subject_name: Midazolam

object_name: respiratory failure with hypoxia


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Inflammatory carcinoma of breast stage IV


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:16646

subject_name: carbohydrate

object_name: COPD exacerbation


subject: CHEBI:16646

object_name: obstructive lung disease


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL


subject: CHEMBL.COMPOUND:CHEMBL2107910


subject: CHEBI:36080

subject_name: protein


subject: CHEBI:36080


subject: UMLS:C0033684

subject_name: Proteins


subject: UMLS:C0033684


subject: PR:000000001


subject: PR:000000001


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEBI:45863

object_name: basaloid squamous cell carcinoma


subject: CHEBI:45863

object_name: undifferentiated pancreatic carcinoma


subject: CHEBI:45863

object_name: undifferentiated carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J

object_name: adenosquamous carcinoma


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester

object_name: Cerebral Vasospasm


subject: PUBCHEM.COMPOUND:3298

object_name: subarachnoid hemorrhage


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:84883


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:15640

subject_name: Leucovorin


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:33276

subject_name: delta-tocotrienol

object_name: pancreatic neoplasm


subject: CHEBI:33276

object_name: exocrine pancreatic carcinoma


subject: CHEBI:33276

object_name: malignant pancreatic neoplasm


subject: UMLS:C4725071

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:135918

subject_name: Tucidinostat


subject: UNII:4JZ0485VXV

subject_name: APLITABART

object_name: Childhood Solid Neoplasm


subject: UNII:4JZ0485VXV

object_name: Adult Solid Neoplasm


subject: UNII:4JZ0485VXV

object_name: Solid Neoplasm


subject: UNII:4JZ0485VXV

object_name: colorectal cancer


subject: UNII:4JZ0485VXV

object_name: colorectal carcinoma


subject: UNII:4JZ0485VXV

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:4JZ0485VXV

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:4JZ0485VXV

object_name: acute myeloid leukemia by FAB classification


subject: UNII:4JZ0485VXV

object_name: acute myeloid leukemia


subject: UNII:4JZ0485VXV

object_name: non-Hodgkin lymphoma


subject: UNII:4JZ0485VXV

object_name: bone chondrosarcoma


subject: UNII:4JZ0485VXV

object_name: chondrosarcoma


subject: UNII:4JZ0485VXV

object_name: malignant soft tissue neoplasm


subject: UNII:4JZ0485VXV

object_name: sarcoma


subject: UMLS:C5447332

subject_name: Aplitabart


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: UMLS:C5447332


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: CHEMBL.COMPOUND:CHEMBL4650399


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: PUBCHEM.COMPOUND:1805


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:177705

subject_name: Birinapant


subject: CHEBI:177705


subject: CHEBI:177705


subject: CHEBI:177705


subject: CHEBI:177705


subject: CHEBI:177705


subject: CHEBI:177705


subject: CHEBI:177705


subject: CHEBI:177705


subject: CHEBI:177705


subject: CHEBI:177705


subject: CHEBI:177705


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: UMLS:C5854622

subject_name: Anti-DLL3/DLL3/CD3 Trispecific Antibody ZG006


subject: UMLS:C5854622


subject: UMLS:C5854622


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C0599934

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:Q5EN532NE7

subject_name: GTP

object_name: osteoporosis


subject: UNII:Q5EN532NE7

object_name: Encounter due to family history of osteoporosis


subject: UNII:Q5EN532NE7

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:Q5EN532NE7

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:37565


subject: CHEBI:37565


subject: CHEBI:37565


subject: CHEBI:37565


subject: CHEBI:39949

subject_name: TRIPHOSPHATE


subject: CHEBI:39949


subject: CHEBI:39949


subject: CHEBI:39949


subject: CHEBI:157903

subject_name: Tyr-Cys


subject: CHEBI:157903


subject: CHEBI:157903


subject: CHEBI:157903


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:33353


subject: UMLS:C0040642

subject_name: Transcobalamin


subject: UMLS:C0040642


subject: UMLS:C0040642


subject: UMLS:C0040642


subject: UMLS:C1704263

subject_name: green tea extract


subject: UMLS:C1704263


subject: UMLS:C1704263


subject: UMLS:C1704263


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: PUBCHEM.COMPOUND:54675776


subject: PUBCHEM.COMPOUND:54675776


subject: PUBCHEM.COMPOUND:54675776


subject: CHEBI:28616

subject_name: Carbamic Acid

object_name: pancreatic neoplasm


subject: CHEBI:28616

object_name: exocrine pancreatic carcinoma


subject: CHEBI:28616

object_name: malignant pancreatic neoplasm


subject: CHEBI:3642

subject_name: Chlorphenesin


subject: CHEBI:3642


subject: CHEBI:3642


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:93109

subject_name: Semaxanib

object_name: Melanoma recurrent


subject: CHEBI:93109


subject: CHEBI:93109


subject: CHEBI:93109

object_name: metastatic melanoma


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:59265

subject_name: palmitelaidic acid

object_name: Chronic inflammation


subject: CHEBI:28716

subject_name: Palmitoleic Acid


subject: CHEBI:6413

subject_name: Letrozole

object_name: ovarian hyperstimulation syndrome


subject: UNII:639NVQ0SXF

subject_name: PP-F11N lutetium Lu-177

object_name: medullary thyroid gland carcinoma


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: Angina pectoris


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Portal Hypertension, CTCAE


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:8802

subject_name: Remifentanil

object_name: delirium


subject: CHEBI:8802

object_name: Delirium, CTCAE


subject: CHEBI:6801

subject_name: Metformin

object_name: migraine


subject: CHEBI:6801

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:52717

subject_name: Bortezomib

object_name: acquired hemophilia A


subject: UMLS:C0592544

subject_name: Zomacton

object_name: Turner syndrome


subject: UMLS:C4764234

subject_name: Nivatrotamab

object_name: Childhood Neuroblastoma


subject: UMLS:C4764234

object_name: neuroblastoma


subject: UMLS:C4764234

object_name: pediatric osteosarcoma


subject: UMLS:C4764234

object_name: Osteosarcoma


subject: UMLS:C2830067

object_name: Neoplasms by Histologic Type


subject: PUBCHEM.COMPOUND:11670360

subject_name: Nirogacestat


subject: CHEBI:17252

subject_name: Hydroxyprogesterone

object_name: Pregnant


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: Induced Abortion Finding


subject: CHEBI:71025

subject_name: ulipristal


subject: UMLS:C2348949

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:91327

subject_name: Tivozanib

object_name: non-small cell lung carcinoma


subject: UMLS:C2830131


subject: CHEBI:229680

subject_name: Rezafungin

object_name: Sepsis


subject: CHEBI:229680

object_name: Sepsis, CTCAE


subject: UNII:T60AV22R32

subject_name: Chlorazine

object_name: Acute Ischemic Stroke


subject: UNII:T60AV22R32

object_name: Ischemic stroke


subject: CHEBI:3647

subject_name: Chlorpromazine


subject: CHEBI:3647


subject: CHEBI:8461

subject_name: Promethazine


subject: CHEBI:8461


subject: CHEBI:64103

subject_name: sodium butyrate

object_name: menstrual symptoms


subject: UMLS:C0142812

subject_name: Sodium Butyrate


subject: CHEBI:30772

subject_name: Butyric Acid


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: recurrent gastric cancer


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IIB Lung Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIA Lung Cancer AJCC v8


subject: CHEBI:31355

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:28241

subject_name: Papaverine

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:28241

object_name: Stage II Lung Cancer AJCC v8


subject: CHEBI:28241

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:28241

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:28241

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:28241


subject: CHEBI:28241


subject: CHEBI:28241

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:28241


subject: UMLS:C5575704

subject_name: Gene Therapy [APC]

object_name: aromatic L-amino acid decarboxylase deficiency


subject: CHEBI:70714

subject_name: Teflaro

object_name: meningitis


subject: CHEBI:70714

object_name: Meningitis, CTCAE


subject: CHEBI:70714

object_name: Avian ventriculitis


subject: CHEBI:70714

object_name: Ventriculitis


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: PUBCHEM.COMPOUND:72562361


subject: PUBCHEM.COMPOUND:72562361


subject: PUBCHEM.COMPOUND:72562361


subject: PR:000006521

subject_name: protein delta homolog 1

object_name: Recurrent tumor


subject: PR:000006521

object_name: Neoplasm Metastasis


subject: UMLS:C2347529

subject_name: Plant-Derived Hematopoiesis Enhancer PG2


subject: UMLS:C2347529


subject: DRUGBANK:DB17855

object_name: Duchenne muscular dystrophy


subject: CHEBI:35366

subject_name: fatty acid

object_name: hypertriglyceridemia


subject: CHEBI:35366

object_name: Hypertriglyceridemia, CTCAE


subject: PUBCHEM.COMPOUND:131648253

subject_name: PEN

object_name: Crohn disease


subject: UNII:66Q80IL7CW

subject_name: Penclomedine


subject: UMLS:C5564908

object_name: long COVID-19


subject: CHEBI:135949

subject_name: Ambrisentan


subject: CHEBI:135949

object_name: Hypoxemia


subject: CHEBI:135949

object_name: Blood oxygen concentration below reference range (finding)


subject: CHEBI:74792

subject_name: Pro-Lys

object_name: Single Ventricle Defect


subject: CHEBI:74792

object_name: Single ventricle


subject: CHEBI:74792

object_name: Neonatal disorder


subject: CHEBI:74792

object_name: Infant, Premature, Diseases


subject: CHEBI:74792

object_name: infant conditions


subject: CHEBI:60948


subject: CHEBI:60948


subject: CHEBI:60948


subject: CHEBI:60948


subject: CHEBI:60948


subject: UMLS:C0034348

subject_name: Pyruvate Kinase


subject: UMLS:C0034348


subject: UMLS:C0034348


subject: UMLS:C0034348


subject: UMLS:C0034348


subject: PR:000009420

subject_name: plasma kallikrein


subject: PR:000009420


subject: PR:000009420


subject: PR:000009420


subject: PR:000009420


subject: UniProtKB:P14272

subject_name: KLKB1_RAT Plasma kallikrein (sprot)


subject: UniProtKB:P14272


subject: UniProtKB:P14272


subject: UniProtKB:P14272


subject: UniProtKB:P14272


subject: UMLS:C0312957

subject_name: Blood group antigen p k


subject: UMLS:C0312957


subject: UMLS:C0312957


subject: UMLS:C0312957


subject: UMLS:C0312957


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: colon carcinoma


subject: CHEBI:41879

object_name: colon cancer


subject: UMLS:C4733623

subject_name: Gammanorm

object_name: Autoimmunity


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Hormone receptor positive breast cancer


subject: CHEBI:31348

object_name: ESR1 Gene Mutation


subject: CHEBI:229213

subject_name: Elacestrant


subject: CHEBI:229213

object_name: breast neoplasm


subject: UMLS:C0592547

subject_name: Movicol

object_name: Chronic constipation


subject: PUBCHEM.COMPOUND:44573417

subject_name: METFORMIN XR

object_name: liver cancer


subject: PUBCHEM.COMPOUND:44573417

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:44573417


subject: PUBCHEM.COMPOUND:44573417

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:44573417

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:44573417

object_name: lymphoma


subject: PUBCHEM.COMPOUND:44573417

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:44573417

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: liver cirrhosis


subject: UNII:6T4O391P5Y

subject_name: Vactosertib

object_name: Locally Advanced Adenocarcinoma


subject: UNII:6T4O391P5Y

object_name: esophageal adenocarcinoma


subject: UNII:6T4O391P5Y

object_name: Siewert type I adenocarcinoma of esophagogastric junction


subject: UNII:6T4O391P5Y

object_name: Siewert type II adenocarcinoma of esophagogastric junction


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:135659064

object_name: malignant pancreatic neoplasm


subject: CHEBI:167661


subject: CHEBI:167661

object_name: exocrine pancreatic carcinoma


subject: CHEBI:167661


subject: UNII:4X6T64D64X

object_name: cellulitis


subject: UNII:4X6T64D64X

object_name: skin infection


subject: UNII:4X6T64D64X

object_name: Skin Infection, CTCAE


subject: CHEBI:50212

subject_name: Pizotifen

object_name: Depressed mood


subject: CHEBI:50212

object_name: Cancer patients and suicide and depression


subject: CHEBI:50212

object_name: Depressed - symptom


subject: CHEBI:50212

object_name: Depression, CTCAE


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: chronic obstructive pulmonary disease


subject: UNII:I031V2H011

object_name: coronary atherosclerosis


subject: UNII:I031V2H011

object_name: chronic kidney disease


subject: UNII:I031V2H011

object_name: Primary malignant neoplasm


subject: UNII:I031V2H011

object_name: childhood malignant neoplasm


subject: UNII:I031V2H011

object_name: Malignant obstetric neoplasm


subject: UNII:I031V2H011

object_name: diabetes mellitus


subject: DRUGBANK:DB09106

subject_name: hetastarch

object_name: Fluid imbalance


subject: UMLS:C0445115

subject_name: Normal saline


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C0379528

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C0379528

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:64216

subject_name: Metergoline

object_name: Dysglycemia


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: gallbladder neoplasm


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: anal canal cancer


subject: UMLS:C4086713

object_name: anal canal carcinoma


subject: UMLS:C4086713

object_name: anal margin carcinoma


subject: UMLS:C4086713

object_name: anal squamous cell carcinoma


subject: UMLS:C4086713

object_name: anus cancer


subject: UMLS:C4086713

object_name: anal carcinoma


subject: UMLS:C4086713

object_name: Anal cancer stage III


subject: CHEBI:229764

subject_name: Selinexor

object_name: Small cell lung cancer extensive stage


subject: GTOPDB:13790

subject_name: benmelstobart


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: PUBCHEM.COMPOUND:156612998

subject_name: Cotadutide

object_name: type 2 diabetes mellitus


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: prolactinoma


subject: CHEBI:172944

subject_name: Cabotegravir


subject: PR:000004912

subject_name: vertebrate-type carbonic anhydrase 1


subject: PR:000007007

subject_name: eukaryotic translation initiation factor 6


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage IIA Cervical Cancer AJCC v7


subject: CHEBI:231679

object_name: Stage IIIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:231679

object_name: Stage II Cervical Cancer AJCC v7


subject: CHEBI:231679

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:231679

object_name: Stage IB2 Cervical Cancer


subject: CHEBI:231679

object_name: cervical adenosquamous carcinoma


subject: CHEBI:231679

object_name: Cervical Squamous Cell Carcinoma, Not Otherwise Specified


subject: CHEBI:63634

subject_name: Valdecoxib

object_name: Low back pain


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: chronic childhood arthritis


subject: UMLS:C0378942


subject: UMLS:C1321997

subject_name: sodium chloride 3 %

object_name: acute bronchiolitis


subject: CHEBI:63610

subject_name: Misoprostol

object_name: DELIVERY UTERINE


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Myelocele


subject: CHEBI:3160

object_name: Open spinal dysraphism with a myelomeningocele


subject: CHEBI:3160

object_name: spina bifida cystica


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Corneal Endothelial Cell Loss


subject: CHEBI:41879

object_name: Corneal decompensation


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Perimenopausal


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: hepatitis B


subject: CHEBI:39548

object_name: Vaccination failure


subject: UMLS:C0354100

subject_name: Loop Diuretics

object_name: Heart failure NYHA class IV


subject: UMLS:C0354100

object_name: Heart failure NYHA class III


subject: MESH:C097921

object_name: breast neoplasm


subject: MESH:C097921

object_name: rectal neoplasm


subject: CHEBI:50819

subject_name: Ferric oxide


subject: CHEBI:50819


subject: CHEBI:28915

subject_name: Fosfomycin

object_name: Urological system complication of procedure


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: myocardial infarction


subject: CHEBI:177406

subject_name: CDDO-Me

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:177406

object_name: Alport syndrome


subject: PUBCHEM.COMPOUND:53315588


subject: PUBCHEM.COMPOUND:53315588


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: complex regional pain syndrome


subject: UNII:PQX0D8J21J

object_name: neuralgia


subject: UNII:PQX0D8J21J

object_name: Neuralgia, CTCAE


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:38867

subject_name: anaesthetic

object_name: spinal cord disorder


subject: UMLS:C0002932

subject_name: Anesthetics


subject: PUBCHEM.COMPOUND:126646947

subject_name: Mirivadelgat

object_name: Group 3 pulmonary hypertension


subject: UNII:22TB7Q431D

subject_name: MIRIVADELGAT


subject: CHEBI:72296

subject_name: Apixaban

object_name: Embolic stroke of undetermined source


subject: UNII:7RPW6SU9SC

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:95067

subject_name: Iniparib

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:95067

object_name: uterine carcinosarcoma


subject: UMLS:C1831868

subject_name: BSI 201


subject: UMLS:C1831868


subject: UMLS:C2587184

subject_name: Parenogen

object_name: Blood Clot


subject: UMLS:C2587184

object_name: thrombosis


subject: UMLS:C2587184

object_name: Thrombosis of blood vessel


subject: UNII:6K15ABL77G

subject_name: HUMAN THROMBIN


subject: UNII:6K15ABL77G


subject: UNII:6K15ABL77G


subject: UMLS:C2369149

subject_name: thrombin, human


subject: UMLS:C2369149


subject: UMLS:C2369149


subject: UMLS:C3195090

subject_name: Evicel


subject: UMLS:C3195090


subject: UMLS:C3195090


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: adrenal gland pheochromocytoma


subject: UNII:GKF8S4C432

object_name: pheochromocytoma


subject: GTOPDB:13790

subject_name: benmelstobart


subject: GTOPDB:13790


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UNII:B25CF42QKP


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: UMLS:C4722710

subject_name: sweet potato extract

object_name: malnutrition


subject: DRUGBANK:DB10648

subject_name: Sweet potato


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Recurrence


subject: CHEBI:68579

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:68579

object_name: Recurrent disease


subject: CHEBI:68579

object_name: Recurrent tumor


subject: CHEBI:124914

subject_name: Voxtalisib

object_name: Childhood Breast Carcinoma


subject: CHEBI:124914

object_name: breast carcinoma


subject: CHEBI:124914

object_name: breast cancer


subject: CHEBI:71958


subject: CHEBI:71958


subject: CHEBI:71958


subject: DRUGBANK:DB05241


subject: DRUGBANK:DB05241


subject: DRUGBANK:DB05241


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: stiff-person syndrome


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:52763

object_name: Idiopathic infantile hypercalcemia - mild form


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Myelofibrosis due to another disorder


subject: UMLS:C2346820


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: dystonia


subject: PUBCHEM.COMPOUND:44602504

subject_name: Etrasimod

object_name: primary biliary cholangitis


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: autoimmune pulmonary alveolar proteinosis


subject: CHEBI:231357

object_name: breast neoplasm


subject: UMLS:C2827515


subject: CHEBI:149509

object_name: hepatitis C


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:73579

subject_name: Leu-Val

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:194537

subject_name: Livermorium


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: GTOPDB:5079

object_name: Advanced renal cell carcinoma


subject: CHEBI:114785

subject_name: Erlotinib

object_name: neoplasm of thorax


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Liquid Tumor


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:2948

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:8ZHS5657EH

subject_name: Tagraxofusp

object_name: leukemia


subject: UNII:8ZHS5657EH

object_name: childhood leukemia


subject: UNII:8ZHS5657EH

object_name: childhood acute myeloid leukemia


subject: UNII:8ZHS5657EH


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: CHEBI:133021

subject_name: Venetoclax


subject: UMLS:C5238967

object_name: graft versus host disease


subject: UMLS:C5222458

subject_name: Ketamine Hydrochloride Injection

object_name: Psychedelic Experiences


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: solar urticaria


subject: CHEBI:51041

subject_name: Acamprosate

object_name: Tinnitus


subject: CHEBI:51041

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:51041

object_name: Tinnitus, CTCAE 3.0


subject: CHEBI:64312

subject_name: Memantine

object_name: aphasia


subject: CHEBI:64312

object_name: stroke disorder


subject: CHEBI:64312

object_name: cerebrovascular disorder


subject: CHEBI:64312

object_name: Stroke (heart beat)


subject: CHEBI:64312

object_name: Stroke, CTCAE


subject: UMLS:C1723266

object_name: Pemphigoid


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: digestive system disorder


subject: CHEBI:4466

object_name: gastrointestinal disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: PR:000011146

object_name: colorectal cancer


subject: PR:000011146

object_name: colorectal carcinoma


subject: PR:000011146

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PR:000011146

object_name: Multiple malignancy


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0885467

object_name: obesity


subject: UMLS:C0885467

object_name: Obesity, CTCAE


subject: CHEBI:86158

subject_name: calcium chloride dihydrate

object_name: head and neck cancer


subject: CHEBI:3312

subject_name: Calol


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: endometriosis


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: UMLS:C1516895

subject_name: Enzyme Replacement or Supplement Agent

object_name: glycogen storage disease II


subject: UMLS:C1516895

object_name: Pompe's disease adult onset


subject: UMLS:C1516895

object_name: glycogen storage disease due to acid maltase deficiency, late-onset


subject: CHEBI:64312

object_name: cocaine abuse


subject: CHEBI:2663

subject_name: Amiodarone

object_name: Premature ventricular contraction


subject: CHEBI:2663

object_name: Ventricular Premature Complex by ECG Finding


subject: UMLS:C5706299

subject_name: Tecadriol

object_name: type 2 diabetes mellitus


subject: UMLS:C5706299

object_name: Insulin resistance


subject: CHEBI:78351

subject_name: amantadine sulfate

object_name: Parkinson disease


subject: CHEBI:177512

subject_name: Sagopilone

object_name: Carcinoma breast stage IV


subject: UMLS:C2930786


subject: UMLS:C2930786

object_name: breast neoplasm


subject: CHEBI:63632

subject_name: Topotecan

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:229599

subject_name: Trofinetide

object_name: fragile X syndrome


subject: UMLS:C2715489


subject: UNII:0709BVY57W

object_name: prostate carcinoma


subject: UNII:0709BVY57W

object_name: prostate cancer


subject: UNII:0709BVY57W

object_name: impotence


subject: UNII:0709BVY57W

object_name: Unable to perform sex


subject: CHEBI:38559

subject_name: cytochrome P450


subject: CHEBI:38559


subject: CHEBI:38559

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C0010762

subject_name: Cytochrome P450


subject: UMLS:C0010762


subject: UMLS:C0010762


subject: CHEBI:4875

subject_name: Etanercept


subject: CHEBI:4875


subject: CHEBI:4875


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: PR:000001959


subject: CHEMBL.COMPOUND:CHEMBL4802258

subject_name: ACAPATAMAB


subject: CHEMBL.COMPOUND:CHEMBL4802258


subject: UMLS:C5446700

subject_name: Acapatamab


subject: UMLS:C5446700


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Recurrent Adult Brain Neoplasm


subject: UMLS:C2346820


subject: UMLS:C5667006

subject_name: BTK Inhibitor HMPL-760

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5667006

object_name: B-cell neoplasm


subject: CHEBI:4953

subject_name: Exemestane

object_name: CYP2D6 polymorphism


subject: CHEBI:139355

subject_name: Methacetin methoxy-C-13

object_name: acute liver failure


subject: UMLS:C4301620

subject_name: methacetin (13C)


subject: CHEBI:15544

subject_name: Alprostadil

object_name: Coronary Slow Flow Phenomenon


subject: CHEBI:15544

object_name: ST-elevation myocardial infarction


subject: CHEBI:4907

subject_name: Etidronic acid

object_name: Root canal infection


subject: CHEBI:4907

object_name: Irreversible pulpitis


subject: CHEBI:4907

object_name: Periapical abscess no sinus


subject: CHEBI:4907

object_name: suppurative periapical periodontitis


subject: CHEBI:4907

object_name: periapical periodontitis


subject: CHEBI:24757

subject_name: Hypochlorite


subject: CHEBI:24757


subject: PUBCHEM.COMPOUND:6916005


subject: PUBCHEM.COMPOUND:6916005


subject: PUBCHEM.COMPOUND:6916005


subject: PUBCHEM.COMPOUND:6916005


subject: PUBCHEM.COMPOUND:6916005


subject: CHEBI:18300

subject_name: Maleic acid


subject: CHEBI:18300


subject: CHEBI:18300


subject: CHEBI:18300


subject: CHEBI:18300


subject: CHEBI:78432

subject_name: Ceritinib

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:78432

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:78432

object_name: inflammatory myofibroblastic tumor


subject: CHEBI:78432

object_name: glioblastoma


subject: CHEBI:78432

object_name: Childhood Glioblastoma


subject: CHEBI:78432

object_name: adult glioblastoma


subject: UMLS:C3852624


subject: UMLS:C3852624


subject: UMLS:C3852624

object_name: anaplastic large cell lymphoma


subject: UMLS:C3852624


subject: UMLS:C3852624


subject: UMLS:C3852624


subject: UMLS:C3852624


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: urothelial carcinoma


subject: CHEBI:141969

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: impotence


subject: PUBCHEM.COMPOUND:18319735

object_name: Erectile Dysfunction, CTCAE


subject: PUBCHEM.COMPOUND:18319735

object_name: Erectile dysfunction


subject: UMLS:C4552025

subject_name: Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine

object_name: lung cancer


subject: UMLS:C4552025

object_name: lung neoplasm


subject: UMLS:C4552025

object_name: lung carcinoma


subject: UMLS:C4552025

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4552025

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4552025

object_name: clear cell renal carcinoma


subject: UMLS:C4552025

object_name: renal cell adenocarcinoma


subject: UMLS:C4552025

object_name: renal cell carcinoma


subject: MESH:D019444

subject_name: Vaccines, DNA

object_name: AIDS


subject: CHEBI:229212

subject_name: Pirtobrutinib

object_name: Multiple sclerosis relapse


subject: CHEBI:229212

object_name: multiple sclerosis


subject: CHEMBL.COMPOUND:CHEMBL5095362

subject_name: VOLRUSTOMIG

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C5417881

subject_name: Volrustomig


subject: UNII:T1JP1KYU9O

subject_name: Flortaucipir F-18

object_name: corticobasal degeneration disorder


subject: UNII:T1JP1KYU9O

object_name: progressive supranuclear palsy


subject: UMLS:C5447334

subject_name: Actinium Ac 225-DOTA-h11B6 JNJ-69086420

object_name: prostate cancer


subject: UMLS:C5447334

object_name: prostate neoplasm


subject: UMLS:C5447334

object_name: esophageal adenocarcinoma


subject: UMLS:C5447334

object_name: lung adenocarcinoma


subject: UMLS:C5447334

object_name: cervical adenocarcinoma


subject: UMLS:C5447334

object_name: adenocarcinoma


subject: UMLS:C5447334

object_name: bile duct adenocarcinoma


subject: UMLS:C5447334

object_name: gastric adenocarcinoma


subject: UMLS:C5556649

subject_name: Anti-KLK2/CD3 Bispecific Antibody JNJ-78278343


subject: UMLS:C5556649


subject: UMLS:C5556649


subject: UMLS:C5556649


subject: UMLS:C5556649


subject: UMLS:C5556649


subject: CHEBI:36939

subject_name: Fluorine F-18

object_name: idiopathic cardiomyopathy


subject: CHEBI:76611

subject_name: flutemetamol


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: traumatic encephalopathy


subject: UNII:UC95NQ339C

object_name: traumatic brain injury


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: CHEMBL.COMPOUND:CHEMBL2109217

subject_name: PERFLUTREN PROTEIN-TYPE A MICROSPHERES

object_name: liver carcinoma


subject: UMLS:C1509955

subject_name: Perflutren Protein-A Microsphere


subject: UMLS:C5417977

subject_name: Wee1 Kinase Inhibitor Debio 0123

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4283130

subject_name: Nigella sativa seed extract

object_name: Hypercholesterolemia


subject: UMLS:C4283130

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C4283130

object_name: metabolic syndrome X


subject: UMLS:C4283130

object_name: diabetes mellitus


subject: UMLS:C4283130

object_name: hypertension


subject: UMLS:C4283130

object_name: Hypertension, CTCAE


subject: DRUGBANK:DB11058

subject_name: Petrolatum

object_name: Inflammation


subject: DRUGBANK:DB11058

object_name: dermatitis


subject: DRUGBANK:DB11058

object_name: Dermatitis


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: CHEBI:29108

subject_name: Calcium cation

object_name: viral disease


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:71255

subject_name: Asenapine

object_name: Agitation, CTCAE 3.0


subject: CHEBI:71255

object_name: Agitation


subject: CHEBI:71255

object_name: Agitation, CTCAE 5.0


subject: CHEBI:71256

subject_name: (R,R)-asenapine


subject: CHEBI:71256


subject: CHEBI:71256


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: methamphetamine dependence


subject: CHEBI:6801

subject_name: Metformin

object_name: Lactic acidosis due to diabetes mellitus


subject: CHEBI:6801

object_name: contrast-induced nephropathy


subject: CHEBI:135207

subject_name: Clofedanol

object_name: mucocutaneous lymph node syndrome


subject: CHEBI:15365

subject_name: Aspirin


subject: UMLS:C0020852

subject_name: immunoglobulin G


subject: UMLS:C3536873

subject_name: Immunoglobulin G [EPC]


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: pulmonary sarcoidosis


subject: MESH:C000712134

subject_name: Del Nido cardioplegia solution

object_name: aortic valve disorder


subject: MESH:C000712134

object_name: aortic valve disease 1


subject: MESH:C000712134

object_name: Aortic Valve Disease, CTCAE


subject: MESH:C000712134

object_name: myocardial ischemia


subject: MESH:C000712134

object_name: coronary atherosclerosis


subject: MESH:C000712134

object_name: heart valve disorder


subject: UMLS:C5433999


subject: UMLS:C5433999


subject: UMLS:C5433999


subject: UMLS:C5433999


subject: UMLS:C5433999


subject: UMLS:C5433999


subject: MESH:C039984

subject_name: Bretschneider cardioplegic solution


subject: MESH:C039984


subject: MESH:C039984


subject: MESH:C039984


subject: MESH:C039984


subject: MESH:C039984


subject: CHEBI:5613

subject_name: Haloperidol

object_name: movement disorder


subject: CHEBI:5613

object_name: lactic acidosis


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: UNII:L1F3R18W77

subject_name: Asciminib

object_name: brain neoplasm


subject: CHEBI:192614

subject_name: Homosildenafil


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Subacromial bursitis


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: post-traumatic stress disorder


subject: CHEBI:26710


subject: CHEBI:8356

subject_name: Pramipexole

object_name: anxiety


subject: CHEBI:8356

object_name: anxiety disorder


subject: CHEBI:8356

object_name: Anxiety symptoms


subject: CHEBI:8356

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:8356

object_name: Anxiety, CTCAE 5.0


subject: PR:000022848

subject_name: guanosine-inosine kinase

object_name: HIV infection


subject: UniProtKB:P0AEW6

subject_name: INGK_ECOLI Guanosine-inosine kinase (sprot)


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Hematoma, Subdural, Chronic


subject: CHEBI:15365

subject_name: Aspirin


subject: UNII:O9YF5SN7KL

subject_name: ROZIBAFUSP ALFA

object_name: EXCESS LMW-DNA


subject: UMLS:C5420958

subject_name: rozibafusp alfa


subject: CHEBI:15552

subject_name: Epoprostenol

object_name: cardiovascular disorder


subject: CHEBI:10023

subject_name: Voriconazole

object_name: cystic fibrosis


subject: UMLS:C0032615

subject_name: Polyunsaturated Fatty Acids

object_name: Fatty Liver


subject: CHEBI:26208

subject_name: polyunsaturated fatty acid


subject: CHEBI:33375

subject_name: Gadolinium

object_name: pulmonary embolism


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEBI:26710

object_name: endogenous depression


subject: CHEBI:26710

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:71526745

object_name: Lipedema


subject: PUBCHEM.COMPOUND:71526745

object_name: adiposis dolorosa


subject: MESH:C000720429


subject: MESH:C000720429


subject: CHEBI:173763

subject_name: Thermophillin

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: CHEBI:4659

subject_name: Disulfiram


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel

object_name: Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: DRUGBANK:DB16582

object_name: Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: UNII:JTZ51LIXN4

subject_name: NEMTABRUTINIB


subject: UNII:JTZ51LIXN4


subject: DRUGBANK:DB18866

subject_name: Nemtabrutinib


subject: DRUGBANK:DB18866


subject: CHEBI:5558

subject_name: Guanfacine

object_name: personality disorder


subject: CHEBI:63634

subject_name: Valdecoxib

object_name: Congenital hallux valgus


subject: CHEBI:63634

object_name: Acquired hallux valgus


subject: CHEBI:63634

object_name: Hallux valgus


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Atopic rhinitis


subject: CHEBI:50847

object_name: Hay fever


subject: CHEBI:42638

subject_name: Flufenamic acid

object_name: influenza A


subject: MESH:D005230

subject_name: Fatty Acids, Nonesterified


subject: CHEBI:3732

subject_name: Clarithromycin


subject: PUBCHEM.COMPOUND:71271414

object_name: Alzheimer disease


subject: UNII:7M430JI73B


subject: CHEBI:67272

subject_name: Perifosine

object_name: kidney neoplasm


subject: CHEBI:18361

object_name: Peptic Ulcer


subject: CHEBI:53266

subject_name: poly(propylene imine) macromolecule


subject: CHEBI:35782

subject_name: diphosphate ion


subject: CHEBI:60614

subject_name: poly(propylene imine) polymer


subject: CHEBI:29888

subject_name: Pyrophosphate


subject: CHEBI:3207

subject_name: Budesonide

object_name: Environmental Exposure


subject: CHEBI:3207

object_name: environmental exposure (history)


subject: UMLS:C3832695

subject_name: Budesonide Nasal (Brand Name)


subject: UMLS:C3832695


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage I Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Gallbladder Cancer AJCC v8


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:48538

subject_name: Apomorphine

object_name: Chronic low back pain


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Fetal Growth Retardation, CTCAE


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:50730

subject_name: Montelukast

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:50730

object_name: COPD, severe early onset


subject: CHEBI:50730

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: Antineoplastic adverse reaction


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Skin Discoloration


subject: UNII:I02418V13W

subject_name: Ziritaxestat

object_name: systemic sclerosis


subject: UMLS:C0064332

subject_name: keyhole-limpet hemocyanin

object_name: melanoma


subject: UNII:TE53TU0WSQ

object_name: hypoparathyroidism


subject: UNII:TE53TU0WSQ

object_name: Hypoparathyroidism, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL1201451

subject_name: ALBUMIN HUMAN

object_name: liver cirrhosis


subject: CHEMBL.COMPOUND:CHEMBL1201451

object_name: Hypervolemia


subject: CHEMBL.COMPOUND:CHEMBL1201451

object_name: Fluid Overload


subject: UMLS:C5203351

subject_name: Furosemide Liquid Injection


subject: UMLS:C4048177

subject_name: furosemide injection


subject: CHEBI:16118

subject_name: Berberine

object_name: Diabetes


subject: MESH:C076628

subject_name: tyramine-deoxysorbitol

object_name: type 2 diabetes mellitus


subject: MESH:C076628


subject: MESH:C076628

object_name: diabetes mellitus


subject: UMLS:C0021735

subject_name: Viraferon

object_name: Adult Solid Neoplasm


subject: UMLS:C1514791

subject_name: Recombinant Vaccinia-CEA


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: Drug Interactions


subject: UNII:UU226QGU97

subject_name: Imeglimin

object_name: QT INTERVAL, VARIATION IN


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Muscle strain


subject: CHEBI:230796

subject_name: Orvepitant

object_name: Pruritus, CTCAE


subject: CHEBI:230796

object_name: Pruritus


subject: CHEBI:230796

object_name: atopic eczema


subject: GTOPDB:4985

object_name: leukemia


subject: GTOPDB:4985

object_name: childhood leukemia


subject: GTOPDB:4985

object_name: myeloid leukemia


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5557672

object_name: Childhood Breast Carcinoma


subject: UMLS:C5557672

object_name: breast carcinoma


subject: UMLS:C5557672

object_name: breast cancer


subject: CHEBI:47657

subject_name: Roflumilast

object_name: diabetic neuropathy


subject: CHEBI:47657

object_name: Type 2 diabetes (Adult onset)


subject: PUBCHEM.COMPOUND:22064497

subject_name: Elagolix

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:22064497

object_name: Menopause


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Behcet disease


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: Her2-receptor negative breast cancer


subject: CHEBI:194186

object_name: hormone receptor-positive breast cancer


subject: HMDB:HMDB0255819

subject_name: Nusinersen

object_name: spinal muscular atrophy, type IV


subject: CHEBI:9168

subject_name: Sirolimus

object_name: prostate carcinoma


subject: CHEBI:9168

object_name: prostate cancer


subject: CHEBI:71940

subject_name: Tadalafil

object_name: glucose intolerance


subject: CHEBI:71940

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:71940

object_name: cardiovascular disorder


subject: CHEBI:71940

object_name: Insulin resistance


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Reading Disabilities


subject: CHEBI:5558

subject_name: Guanfacine


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:6456

subject_name: Lidocaine

object_name: female reproductive organ cancer


subject: CHEBI:6456

object_name: sexual disorder


subject: CHEBI:6456

object_name: physiological sexual disorder


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:114785

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:91899

object_name: Small airways disease


subject: CHEBI:91899

object_name: Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:127342

object_name: Substance Use Disorders


subject: PUBCHEM.COMPOUND:155586901

object_name: metastatic prostate carcinoma


subject: MESH:C000615411

object_name: Disseminated Malignant Neoplasm


subject: MESH:C000615411

object_name: Embolism, Tumor


subject: MESH:C000615411

object_name: Neoplasm Metastasis


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Tendinopathy


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:174615

object_name: Signs and Symptoms, Respiratory


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: periodontitis, chronic, adult


subject: CHEBI:63611

object_name: chronic periodontitis


subject: CHEBI:131174

subject_name: Navitoclax

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:131174

object_name: Non-small cell lung cancer stage III


subject: CHEBI:131174

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:131174

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:131174

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEBI:131174

object_name: Advanced Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: MESH:C000730795

object_name: Chronic Insomnia


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Mycosis fungoides refractory


subject: UNII:7XL5ISS668

object_name: Mycosis fungoides recurrent


subject: UNII:7XL5ISS668

object_name: folliculotropic mycosis fungoides


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: CD30-Positive Neoplastic Cells Present


subject: CHEBI:195544

subject_name: Aspartame

object_name: glucose metabolism disease


subject: UMLS:C1257722

subject_name: Canderel


subject: UMLS:C2346797

object_name: adult lymphoma


subject: UMLS:C2346797

object_name: lymphoma


subject: UMLS:C2346797

object_name: pediatric lymphoma


subject: UMLS:C0700926

subject_name: Ancef

object_name: pneumothorax


subject: UMLS:C0700926

object_name: Pneumothorax, CTCAE


subject: UMLS:C0700926

object_name: hemopneumothorax


subject: CHEBI:474053

subject_name: Cefazolin


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:3745


subject: CHEBI:3745


subject: CHEBI:74705

subject_name: Met-Leu

object_name: cerebral atherosclerosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:6456

subject_name: Lidocaine

object_name: meningitis


subject: CHEBI:6456

object_name: Meningitis, CTCAE


subject: UNII:832663U2NB

subject_name: Apararenone


subject: UMLS:C5566015


subject: CHEBI:45285

subject_name: Pyrazinamide

object_name: HIV-1 infection


subject: CHEBI:4877

subject_name: Ethambutol


subject: CHEBI:133023

subject_name: Lifitegrast

object_name: xerophthalmia


subject: CHEBI:2569

subject_name: Alfentanil

object_name: nephrolithiasis


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: Well adult


subject: CHEBI:2549

subject_name: Albuterol

object_name: persistent fetal circulation syndrome


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: morbid obesity


subject: CHEMBL.COMPOUND:CHEMBL2107910

object_name: Class 3 Obesity


subject: CHEBI:231693

subject_name: Capmatinib

object_name: MET Exon 14 Mutation


subject: CHEBI:231693

object_name: BRAF V600 Protein Variation


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:75998

subject_name: Trametinib


subject: UNII:HG3L8885M0

subject_name: zanolimumab

object_name: metastatic melanoma


subject: UNII:HG3L8885M0

object_name: Renal cancer metastatic


subject: UMLS:C1328138


subject: UMLS:C1328138


subject: GTOPDB:8313

subject_name: talazoparib

object_name: peritoneum cancer


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694


subject: UMLS:C4287690

object_name: fallopian tube carcinoma


subject: UMLS:C4287690

object_name: fallopian tube cancer


subject: UMLS:C2826229

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:132082

subject_name: Entinostat

object_name: HER2 positive breast carcinoma


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994

object_name: Childhood Breast Carcinoma


subject: UMLS:C4086994

object_name: breast carcinoma


subject: UMLS:C4086994

object_name: breast cancer


subject: UMLS:C4086994

object_name: Carcinoma breast stage IV


subject: CHEBI:76842

object_name: complications of organ transplant stem cells


subject: CHEBI:28001

subject_name: Vancomycin


subject: UNII:PFP09575EX

object_name: Early Stage Breast Carcinoma


subject: UNII:PFP09575EX

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UNII:PFP09575EX

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:PFP09575EX

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:PFP09575EX

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UNII:PFP09575EX

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:PFP09575EX

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:PFP09575EX

object_name: invasive breast carcinoma


subject: UNII:PFP09575EX

object_name: ductal breast carcinoma in situ


subject: PUBCHEM.COMPOUND:54201037

subject_name: Retinoid 9CUAB30


subject: PUBCHEM.COMPOUND:54201037


subject: PUBCHEM.COMPOUND:54201037


subject: PUBCHEM.COMPOUND:54201037


subject: PUBCHEM.COMPOUND:54201037


subject: PUBCHEM.COMPOUND:54201037


subject: PUBCHEM.COMPOUND:54201037


subject: PUBCHEM.COMPOUND:54201037


subject: PUBCHEM.COMPOUND:54201037


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: stage IIIC melanoma


subject: UMLS:C0379528

object_name: stage IIIB melanoma


subject: CHEBI:60799

subject_name: Esketamine

object_name: Parkinson disease


subject: UMLS:C5235210

object_name: kidney failure


subject: UNII:1W10Q5H7WD

subject_name: Giripladib

object_name: rheumatoid arthritis


subject: CHEBI:16919

subject_name: Creatine

object_name: Complication of dialysis


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Recurrent Endometrial Serous Adenocarcinoma


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: PUBCHEM.COMPOUND:24984318

subject_name: Valbenazine

object_name: Compulsion


subject: UNII:WO97N24A47

subject_name: Miridesap

object_name: HIV infection


subject: UNII:C88817F47Y

object_name: Recurrent Rhabdomyosarcoma


subject: UMLS:C5203802

subject_name: Samotolisib


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic tumors of the Ewing's family


subject: CHEBI:231679

object_name: bone chondrosarcoma


subject: CHEBI:231679

object_name: chondrosarcoma


subject: CHEBI:231679

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: CHEBI:231679

object_name: desmoplastic small round cell tumor


subject: CHEBI:231679

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: CHEBI:231679

object_name: Ewing's tumor recurrent


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: type 1 diabetes mellitus


subject: CHEBI:28939

object_name: Loss of hypoglycemic warning due to diabetes mellitus


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: interstitial cystitis


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:3764

subject_name: Clotrimazole

object_name: vaginal discharge


subject: CHEBI:3764

object_name: Vaginal Discharge, CTCAE


subject: CHEBI:3764

object_name: Vaginal Discharge


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: UMLS:C3490787

subject_name: BF-200 ALA

object_name: skin basal cell carcinoma


subject: CHEBI:32599

object_name: Perioperative complication


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: endometrial cancer


subject: UNII:M487QF2F4V

object_name: uterine corpus cancer


subject: UNII:M487QF2F4V

object_name: endometrial carcinoma


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: UNII:U09Q76B8VK

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:U09Q76B8VK

object_name: follicular lymphoma


subject: UNII:U09Q76B8VK

object_name: marginal zone lymphoma


subject: UNII:U09Q76B8VK

object_name: MALT lymphoma


subject: UMLS:C4053639

subject_name: PI3Kdelta Inhibitor GS-9901


subject: UMLS:C4053639


subject: UMLS:C4053639


subject: UMLS:C4053639


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:34945

object_name: multiple sclerosis


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: NK/T-cell lymphoma, nasal and nasal-type


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:131648253

subject_name: PEN

object_name: rheumatoid arthritis


subject: UNII:66Q80IL7CW

subject_name: Penclomedine


subject: UMLS:C0032375

subject_name: Oral Poliovirus Vaccine

object_name: influenza


subject: UMLS:C0032375

object_name: pertussis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Xerostomia


subject: CHEBI:31355


subject: CHEBI:5864

subject_name: Ifosfamide


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: asthma


subject: CHEBI:149504

object_name: aorta coarctation


subject: CHEBI:6541

subject_name: Losartan


subject: GTOPDB:11546

subject_name: aldafermin

object_name: chronic diarrheal disease


subject: GTOPDB:11546

object_name: Bile acid malabsorption


subject: GTOPDB:11546

object_name: Bile acid diarrhea


subject: GTOPDB:11546

object_name: Bile acid malabsorption syndrome type II


subject: GTOPDB:11546

object_name: functional diarrhea


subject: GTOPDB:11546

object_name: Irritable bowel syndrome with diarrhea


subject: CHEMBL.COMPOUND:CHEMBL4298055

subject_name: ALDAFERMIN


subject: CHEMBL.COMPOUND:CHEMBL4298055


subject: CHEMBL.COMPOUND:CHEMBL4298055


subject: CHEMBL.COMPOUND:CHEMBL4298055


subject: CHEMBL.COMPOUND:CHEMBL4298055


subject: CHEMBL.COMPOUND:CHEMBL4298055


subject: UMLS:C5418311


subject: UMLS:C5418311


subject: UMLS:C5418311


subject: UMLS:C5418311


subject: UMLS:C5418311


subject: UMLS:C5418311


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: amyloidosis


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: familial pityriasis rubra pilaris


subject: UNII:BTY153760O

object_name: pityriasis rubra pilaris


subject: UMLS:C5907912

subject_name: IL-2/IL-12-based Fusion Protein CLN-617

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:9518

subject_name: theasinensin A

object_name: central nervous system embryonal neoplasm


subject: CHEBI:9518

object_name: ependymoblastoma


subject: CHEBI:9518

object_name: embryonal tumor with multilayered rosettes


subject: CHEBI:9518

object_name: Atypical teratoid/rhabdoid tumour of central nervous system


subject: CHEBI:9518

object_name: childhood medulloblastoma


subject: CHEBI:9518

object_name: Childhood Pineoblastoma


subject: CHEBI:9518

object_name: pineoblastoma


subject: CHEBI:9518

object_name: adult pineoblastoma


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P52570

subject_name: 1CPX_ONCVO 1-Cys peroxiredoxin (sprot)


subject: UniProtKB:P52570


subject: UniProtKB:P52570


subject: UniProtKB:P52570


subject: UniProtKB:P52570


subject: UniProtKB:P52570


subject: UniProtKB:P52570


subject: UniProtKB:P52570


subject: CHEBI:91570

subject_name: trichostatin A


subject: CHEBI:91570


subject: CHEBI:91570


subject: CHEBI:91570


subject: CHEBI:91570


subject: CHEBI:91570


subject: CHEBI:91570


subject: CHEBI:91570


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: antiphospholipid syndrome


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C2608320

subject_name: Aspirin Low Dose


subject: CHEBI:87681

subject_name: Ranolazine

object_name: dilated cardiomyopathy


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: Upper Respiratory Infections


subject: UNII:43K1W2T1M6

object_name: respiratory tract infectious disorder


subject: UNII:43K1W2T1M6

object_name: Recurrent upper respiratory tract infections


subject: CHEBI:197268

subject_name: Tocotrienol

object_name: cystic fibrosis


subject: UMLS:C3831008

subject_name: Copper Cu 64 Plerixafor

object_name: cancer


subject: UMLS:C3831008

object_name: neoplasm


subject: CHEBI:80489

subject_name: desmethylxanthohumol

object_name: inflammatory bowel disease 1


subject: CHEBI:80489

object_name: Crohn disease


subject: CHEBI:66331

subject_name: Xanthohumol


subject: CHEBI:66331


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: autoimmune thrombocytopenia


subject: CHEBI:55379

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:55379

object_name: autoimmune thrombocytopenic purpura


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: PR:000007170


subject: PR:000007170


subject: CHEBI:2453

subject_name: Acyclovir

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:4689

subject_name: Paromomycin I

object_name: Post-kala-azar dermal leishmaniasis


subject: CHEBI:233202


subject: CHEBI:7934

subject_name: Paromomycin


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Pediatric respiratory diseases


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin

object_name: malignant epithelial tumor of ovary


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: anti-NMDA receptor encephalitis


subject: UMLS:C1541395


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Traumatic Wound


subject: CHEBI:6456

object_name: Injury


subject: PUBCHEM.COMPOUND:439262

subject_name: Beta-Glucan

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:439262

object_name: obesity


subject: PUBCHEM.COMPOUND:439262

object_name: Obesity, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: ST-segment elevation myocardial infarction (STEMI)


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: PUBCHEM.COMPOUND:160283094

subject_name: ZONGERTINIB

object_name: non-small cell squamous lung carcinoma


subject: UNII:DRH7R67UVL


subject: UNII:0N3V8R4E13

subject_name: DACA, acridine

object_name: lung cancer


subject: UNII:0N3V8R4E13

object_name: lung neoplasm


subject: UNII:0N3V8R4E13

object_name: lung carcinoma


subject: UNII:41XGO0VS1U

object_name: nasopharyngeal carcinoma


subject: UNII:41XGO0VS1U

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:3811W2NBZ8

object_name: unspecified adult solid tumor, protocol specific


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: Sepsis


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: Sepsis, CTCAE


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: CHEBI:47897

subject_name: Iododoxorubicin

object_name: AL amyloidosis


subject: CHEBI:47897

object_name: primary systemic amyloidosis


subject: UMLS:C1948073

object_name: HIV infection


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Evidence of liver transplantation


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Meibomianitis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: MESH:D002214

subject_name: Capsules

object_name: blepharitis


subject: MESH:D002214


subject: MESH:D002214

object_name: dry eye syndrome


subject: MESH:D002214

object_name: Dry Eye, CTCAE


subject: MESH:D002214

object_name: Dryness of eye


subject: UMLS:C5783886

subject_name: Anti-PSMA/CD3 Protease-activated T-cell Engager JANX007

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C5783886

object_name: prostate carcinoma


subject: UMLS:C5783886

object_name: prostate cancer


subject: UMLS:C5783886

object_name: Prostatic Cancer, Castration-Resistant


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: adverse effect


subject: CHEBI:3215

object_name: Adverse effects


subject: CHEBI:3215

object_name: Adverse reactions


subject: CHEBI:63627

subject_name: Tinidazole

object_name: chronic diarrheal disease


subject: CHEBI:63627

object_name: Meteorism


subject: CHEBI:63627

object_name: Bloating, CTCAE


subject: CHEBI:63627

object_name: Abdominal distention


subject: CHEBI:63627

object_name: Abdominal pain


subject: CHEBI:63627

object_name: Abdominal Pain, CTCAE


subject: CHEBI:16664

subject_name: Albendazole


subject: CHEBI:16664


subject: CHEBI:16664


subject: CHEBI:16664


subject: CHEBI:16664


subject: UMLS:C3898767

subject_name: Inducer

object_name: glucose intolerance


subject: UMLS:C3898767

object_name: Glucose Intolerance, CTCAE


subject: UMLS:C3898767

object_name: Vasodilation disorder


subject: UMLS:C3898767

object_name: Aortic stiffness


subject: UMLS:C4507249

object_name: diffuse cutaneous systemic sclerosis


subject: UMLS:C4507249

object_name: diffuse scleroderma


subject: UMLS:C4507249

object_name: systemic sclerosis


subject: UMLS:C4727777

object_name: primary hyperparathyroidism


subject: UMLS:C4727777

object_name: parathyroid gland carcinoma


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: Childhood Breast Carcinoma


subject: CHEBI:135285

object_name: breast carcinoma


subject: CHEBI:135285

object_name: breast cancer


subject: CHEBI:174615

object_name: Childhood Solid Neoplasm


subject: CHEBI:174615

object_name: Adult Solid Neoplasm


subject: CHEBI:174615

object_name: Solid Neoplasm


subject: CHEBI:174615

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:174615

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:174615

object_name: recurrent extragonadal germ cell tumor


subject: CHEBI:174615

object_name: ovarian mixed germ cell neoplasm


subject: CHEBI:174615

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:174615

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:174615

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:174615

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:174615

object_name: recurrent extragonadal non-seminomatous germ cell tumor


subject: CHEBI:174615

object_name: adult central nervous system germ cell tumor


subject: CHEBI:174615

object_name: Recurrent Childhood Pineoblastoma


subject: CHEBI:174615

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:174615

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:174615

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:174615

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:174615

object_name: Recurrent Childhood Visual Pathway Glioma


subject: CHEBI:174615

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:174615

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: CHEBI:174615

object_name: previously untreated childhood rhabdomyosarcoma


subject: CHEBI:174615

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:28901

subject_name: Busulfan

object_name: Childhood Solid Neoplasm


subject: CHEBI:28901

object_name: Adult Solid Neoplasm


subject: CHEBI:28901

object_name: Solid Neoplasm


subject: CHEBI:28901

object_name: Recurrent Ovarian Germ Cell Tumor